FAKTOR-OPTIONSSCHEIN - ORION B | Delayed Börse Stuttgart 07:43:34 2024-06-26 EDT | ||
| 2.37 EUR | +5.80% |
|
| Current month | -37.43% | ||
| 1 month | -40.74% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ORION OYJ
Latest news about ORION OYJ
More news
| Date | Price | Change |
|---|---|---|
| 24-06-26 | 2.37 | +5.80% |
| 24-06-25 | 2.24 | -0.88% |
| 24-06-24 | 2.26 | -8.87% |
| 24-06-21 | 2.48 | +3.77% |
| 24-06-20 | 2.39 | -20.86% |
Delayed Quote Börse Stuttgart
Last update June 26, 2024 at 07:43 am
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | ORION OYJ |
| Issuer | Morgan Stanley |
| WKN | MG2WH8 |
| ISIN | DE000MG2WH83 |
| Date issued | 2024-04-24 |
| Strike | 46.51 € |
| Maturity | Unlimited |
| Parity | 2.9 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.66 € |
|---|---|
| Lowest since issue | 2.24 € |
| Spread | 0.05 € |
| Spread % | 2.07% |
Company Profile
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows:
- generic, OTC and biosimilar drugs (43.4%);
- patented prescription products (41.7%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments;
- animal health products (8.7%);
- pharmaceutical ingredients and outsourcing services (6.2%).
Net sales break down primarily by source of revenue between sales of products (86.9%) and royalties (10.4%).
Net sales are distributed geographically as follows: Finland (28%), Scandinavia (12%), Europe (30.8%), North America (14.7%) and other (14.5%).
Sector
-
Consensus: Orion Oyj
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
39.87
EUR
Average target price
38.2
EUR
Spread / Average Target
-4.19%
- Stock Market
- Certificates
- Certificat
